Advanced Therapies, LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 400 Rouse Blvd, Philadelphia, Pennsylvania (PA) 19112, United States (USA)
- Operations here
- analysis
- FDA identifiers
- FEI 1000122198 · DUNS 117556312
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIHuman Cellular, Tissue, and Gene Therapies2025-11-25
- NAIDrug Quality Assurance2025-02-07
- NAIDrug Quality Assurance2020-01-22
- VAIDrug Quality Assurance2015-04-17
- NAIHuman Cellular, Tissue, and Gene Therapies2013-09-12
- NAIDrug Quality Assurance2012-08-24
- NAIDrug Quality Assurance2010-01-06
Drugs this plant is listed as making
1 distinct drugs across 1 products name this site in their FDA label.
- zopapogene imadenovecPrecigen, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.